Molecular and point-of-care diagnostics for Ebola and new threats: National POCT policy and guidelines will stop epidemics

References

• Global point of care: strategies for Disasters, Emergencies, and Public Health Resilience. Kost GJ, Curtis C Assoc., Ed. Washington DC: AACC Press-Elsevier; 2015.
   Google Scholar
• A practical guide to global point-of-care testing. Shephard M, Ed. Australia: CSIRO (Commonwealth Scientific and Industrial Research Organization); 2016.
   Google Scholar
• Kost GJ, Ferguson WJ. Spatial Care PathsTM strengthen links in the chain of global resilience: disaster caches, prediabetes, Ebola virus disease, and the future of point of care. Point Care. 2015;15:43–58.
   Web of Science ®Google Scholar
• Acquah C, Danquah MK, Agyei D, et al. Deploying aptameric sensing technology for rapid pandemic monitoring. Crit Rev Biotechnol. 2016;36(6):1010–1022.
   PubMed Web of Science ®Google Scholar
• Barocchi MA, Rappuoli R. Delivering vaccines to the people who need them most. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences. 2015;370:1671.
   Web of Science ®Google Scholar
• Bhadelia N. Rapid diagnostics for Ebola in emergency settings. Lancet. (London, England) 2015;386(9996):833–835.
   PubMed Web of Science ®Google Scholar
• Coarsey CT, Esiobu N, Narayanan R, et al. Strategies in Ebola virus disease (EVD) diagnostics at the point of care. Crit Rev Microbiol. 2017;43(6):779–798.
   PubMed Web of Science ®Google Scholar
• Dhama K, Malik YS, Malik SV, et al. Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives. J Infect Dev Ctries. 2015;9(5):441–455.
   PubMed Web of Science ®Google Scholar
• Emergency Use FDA. Authorization of medical products and related authorities: guidance for industry and other stakeholders. Silver Springs, MD, Scientist OotC. Contract No.: OMB Control No. 0910-0595. [2017 Jan 1];
   Google Scholar
• Feldmann H, Jones S, Klenk HD, et al. Ebola virus: from discovery to vaccine. Nat Reviews Immunol. 2003;3(8):677–685.
   PubMed Web of Science ®Google Scholar
• Gardy JL, Loman NJ. Towards a genomics-informed, real-time, global pathogen surveillance system. Nat Reviews Genet. 2018;19(1):9–20.
   PubMed Web of Science ®Google Scholar
• Gilbert GL. Laboratory testing in management of patients with suspected Ebola virus disease: infection control and safety. Pathology. 2015;47(5):400–402.
   PubMed Web of Science ®Google Scholar
• Gonzalez VM, Martin ME, Fernandez G, et al. Use of aptamers as diagnostics tools and antiviral agents for human viruses. Pharmaceuticals . (Basel, Switzerland) 2016;9:4.
   Web of Science ®Google Scholar
• Grolla A, Jones S, Kobinger G, et al. Flexibility of mobile laboratory unit in support of patient management during the 2007 Ebola-Zaire outbreak in the Democratic Republic of Congo. Zoonoses Public Health. 2012;59(Suppl 2):151–157.
   PubMedGoogle Scholar
• Grolla A, Lucht A, Dick D, et al. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bulletin De La Societe De Pathologie Exotique. 2005;98(3):205–209.
   PubMedGoogle Scholar
• Kager PA. [Viral hemorrhagic fever]. Ned Tijdschr Geneeskd. 1998;142(9):448–451.
   PubMedGoogle Scholar
• Kaushik A, Tiwari S, Dev Jayant R, et al. Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosensors & Bioelectronics. 2016;75:254–272.
   PubMed Web of Science ®Google Scholar
• Kost GJ, Ferguson WJ, Truong A-T, et al. The Ebola Spatial Care PathTM: lessons learned from stopping outbreaks. Clin Lab International. 2015;39:6–14.
   Google Scholar
• Logue CH, Lewis SM, Lansley A, et al. Case study: design and implementation of training for scientists deploying to Ebola diagnostic field laboratories in Sierra Leone: October 2014 to February 2016. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences. 2017;372:1721.
   Web of Science ®Google Scholar
• Lowenthal J. Overview of the CSIRO Australian animal health laboratory. J Infect Public Health. 2016;9(3):236–239.
   PubMed Web of Science ®Google Scholar
• Mann P. Describing a point-of-care Coordinator’s potential role in disasters and complex emergencies. In: Kost GJ, Curtis C Assoc.Ed. Global point of care: strategies for Disasters, Emergencies, and Public Health Resilience. Washington DC:AACC Press-Elsevier; 2015.chapter 31,356–3447.
   Google Scholar
• Nakayama E, Saijo M. Animal models for Ebola and Marburg virus infections. Front Microbiol. 2013;4:267.
   PubMed Web of Science ®Google Scholar
• Nouvellet P, Garske T, Mills HL, et al. The role of rapid diagnostics in managing Ebola epidemics. Nature. 2015;528(7580):S109–16.
   PubMed Web of Science ®Google Scholar
• Otter JA. What’s trending in the infection prevention and control literature? From HIS 2012 to HIS 2014, and beyond. J Hosp Infect. 2015;89(4):229–236.
   PubMed Web of Science ®Google Scholar
• Perkins MD, Dye C, Balasegaram M, et al. Diagnostic preparedness for infectious disease outbreaks. Lancet. (London, England) 2017;390(10108):2211–2214.
   PubMed Web of Science ®Google Scholar
• Racsa LD, Kraft CS, Olinger GG, et al. Viral Hemorrhagic fever diagnostics. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2016;62(2):214–219.
   PubMed Web of Science ®Google Scholar
• Roca A, Afolabi MO, Saidu Y, et al. Ebola: a holistic approach is required to achieve effective management and control. J Allergy Clin Immunol. 2015;135(4):856–867.
   PubMed Web of Science ®Google Scholar
• Saijo M, Morita K. Preparedness for ebolavirus disease outbreak in Japan: necessity of biosafety level-4 facility. Uirusu. 2015;65(1):89–94.
   PubMedGoogle Scholar
• Shorten RJ, Brown CS, Jacobs M, et al. Diagnostics in Ebola Virus disease in resource-rich and resource-limited settings. PLoS Negl Trop Dis. 2016;10(10):e0004948.
   PubMed Web of Science ®Google Scholar
• Shurtleff AC, Whitehouse CA, Ward MD, et al. Pre-symptomatic diagnosis and treatment of filovirus diseases. Front Microbiol. 2015;6:108.
   PubMed Web of Science ®Google Scholar
• Singh B, Ganguly A, Sunwoo HH. Current and future diagnostic tests for Ebola Virus disease. Journal of Pharmacy & Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques. 2016;19(4):530–551.
   PubMedGoogle Scholar
• Singh RK, Dhama K, Malik YS, et al. Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year’s journey. Vet Q. 2017;37(1):98–135.
   PubMed Web of Science ®Google Scholar
• Steele KE, Alves DA, Chapman JL. Challenges in biodefense research and the role of US Army veterinary pathologists. US Army Medical Department Journal. 2007;28–37. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20088227
   PubMedGoogle Scholar
• Stroher U, Feldmann H. Progress towards the treatment of Ebola haemorrhagic fever. Expert Opin Investig Drugs. 2006;15(12):1523–1535.
   PubMed Web of Science ®Google Scholar
• Titenko AM. [Filovirus haemorrhagic fevers: ebola fever]. Zh Mikrobiol Epidemiol Immunobiol. 2002(5):116–122.Available from: https://www.ncbi.nlm.nih.gov/pubmed/12525016
   Google Scholar
• Wadman MC, Schwedhelm SS, Watson S, et al. Emergency department processes for the evaluation and management of persons under investigation for Ebola Virus Disease. Ann Emerg Med. 2015;66(3):306–314.
   PubMed Web of Science ®Google Scholar
• Wandtke T, Wozniak J, Kopinski P. Aptamers in diagnostics and treatment of viral infections. Viruses. 2015;7(2):751–780.
   PubMed Web of Science ®Google Scholar
• Wang S, Lifson MA, Inci F, et al. Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings. Expert Rev Mol Diagn. 2016;16(4):449–459.
   PubMed Web of Science ®Google Scholar
• Whitehouse CA, Bavari S, Perkins MD. United States FDA’s emergency use authorization of Ebola virus diagnostics: current impact and lessons for the future. Expert Rev Mol Diagn. 2015;15(10):1231–1235.
   PubMed Web of Science ®Google Scholar
• Woolhouse ME, Rambaut A, Kellam P. Lessons from Ebola: improving infectious disease surveillance to inform outbreak management. Sci Transl Med. 2015;7(307):307rv5.
   PubMed Web of Science ®Google Scholar
• Bradfute SB, Warfield KL, Bray M. Mouse models for filovirus infections. Viruses. 2012;4(9):1477–1508.
   PubMed Web of Science ®Google Scholar
• Ignatiev GM, Dadaeva AA, Luchko SV, et al. Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs. Immunol Lett. 2000;71(2):131–140.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003;163(6):2347–2370.
   PubMed Web of Science ®Google Scholar
• Kost GJ, Zadran A, Sayneko M, et al. The environmental robustness of a point-of-care WBC-differential instrument used to screen for highly infectious diseases. WorldLab2017—International Congress of Clinical Chemistry and Laboratory Medicine, Meeting of the South African Association for Clinical Biochemistry, and Congress of the African Federation of Clinical Chemistry; Durban, South Africa, October 22-25, 2017.
   Google Scholar
• Ahrberg CD, Manz A, Palm-Sized NP. Device for point-of-care Ebola detection. Anal Chem. 2016;88(9):4803–4807.
   PubMed Web of Science ®Google Scholar
• Boisen ML, Oottamasathien D, Jones AB, et al. Development of Prototype Filovirus Recombinant Antigen Immunoassays. J Infect Dis. 2015;212(Suppl 2):S359–67.
   PubMedGoogle Scholar
• Brangel P, Sobarzo A, Parolo C, et al. A serological point-of-care test for the detection of IgG antibodies against Ebola Virus in Human Survivors. ACS Nano. 2018;12(1):63–73.
   PubMed Web of Science ®Google Scholar
• Brinkmann A, Ergunay K, Radonic A, et al. Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics. PLoS Negl Trop Dis. 2017;11(11):e0006075.
   PubMed Web of Science ®Google Scholar
• Broadhurst MJ, Brooks TJ, Pollock NR. Diagnosis of Ebola Virus Disease: past, present, and future. Clin Microbiol Rev. 2016;29(4):773–793.
   PubMed Web of Science ®Google Scholar
• Broadhurst MJ, Kelly JD, Miller A, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. (London, England) 2015;386(9996):867–874.
   PubMed Web of Science ®Google Scholar
• Cao J, Senn C, Castaneda P, et al. Establishing a stand-alone laboratory dedicated to the Care of Patients with Ebola Virus Disease. Lab Med. 2017;48(2):188–194.
   PubMed Web of Science ®Google Scholar
• Chan K, Wong PY, Yu P, et al. A rapid and low-cost PCR thermal cycler for infectious disease diagnostics. PloS One. 2016;11(2):e0149150.
   PubMed Web of Science ®Google Scholar
• Cnops L, Van Den Eede P, Pettitt J, et al. Development, evaluation, and integration of a quantitative reverse transcription polymerase chain reaction diagnostic test for Ebola virus on a molecular diagnostics platform. J Infect Dis. 2016;214(Suppl 3):S192–202.
   PubMedGoogle Scholar
• Cotte J, Janvier F, Cordier PY, et al. Organ support in Ebola virus disease: utility of point-of-care blood tests. Anaesthesia, Critical Care & Pain Medicine. 2015;34(6):363–364.
   PubMed Web of Science ®Google Scholar
• Cross RW, Boisen ML, Millett MM, et al. Analytical validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection. J Infect Dis. 2016;214(suppl 3):S210–s7.
   PubMedGoogle Scholar
• Cross RW, Ksiazek TG. ELISA methods for the detection of Ebolavirus infection. Methods in Molecular Biology. (Clifton, NJ) 2017;1628:363–372.
   PubMedGoogle Scholar
• de La Vega MA, Bello A, Chaillet P, et al. Diagnosis and management of Ebola samples in the laboratory. Expert Rev Anti Infect Ther. 2016;14(6):557–567.
   PubMed Web of Science ®Google Scholar
• de Wit E, Kramer S, Prescott J, et al. Clinical chemistry of patients with Ebola in Monrovia, Liberia. J Infect Dis. 2016;214(suppl 3):S303–s7.
   PubMedGoogle Scholar
• Dedkov VG, Magassouba N, Safonova MV, et al. Sensitive multiplex real-time RT-qPCR assay for the Detection of Filoviruses. Health Security. 2018;16(1):14–21.
   PubMed Web of Science ®Google Scholar
• Diarra B, Safronetz D, Sarro YD, et al. Laboratory response to 2014 Ebola Virus outbreak in Mali. J Infect Dis. 2016;214(suppl 3):S164–s8.
   PubMedGoogle Scholar
• Du Y, Hughes RA, Bhadra S, et al. A sweet spot for molecular diagnostics: coupling isothermal amplification and strand exchange circuits to glucometers. Sci Rep. 2015;5:11039.
   PubMed Web of Science ®Google Scholar
• Du Y, Pothukuchy A, Gollihar JD, et al. Coupling sensitive nucleic acid amplification with commercial pregnancy test strips. Angewandte Chemie (International Ed in English). 2017;56(4):992–996.
   PubMed Web of Science ®Google Scholar
• Fallah MP, Skrip LA, Raftery P, et al. Bolstering community cooperation in Ebola resurgence protocols: combining field blood draw and point-of-care diagnosis. PLoS Med. 2017;14(1):e1002227.
   PubMed Web of Science ®Google Scholar
• Flint M, Goodman CH, Bearden S, et al. Ebola Virus diagnostics: the US Centers for disease control and prevention laboratory in Sierra Leone, August 2014 to March 2015. J Infect Dis. 2015;212(Suppl 2):S350–8.
   PubMedGoogle Scholar
• Gay-Andrieu F, Magassouba N, Picot V, et al. Clinical evaluation of the BioFire FilmArray(I) BioThreat-E test for the diagnosis of Ebola Virus Disease in Guinea. J Clinical Virology: Official Publication Pan Am Soc Clin Virol. 2017;92:20–24.
   PubMed Web of Science ®Google Scholar
• Hill CE, Burd EM, Kraft CS, et al. Laboratory test support for Ebola patients within a high-containment facility. Lab Med. 2014;45(3):e109–11.
   PubMedGoogle Scholar
• Irenge LM, Dindart JM, Gala JL. Biochemical testing in a laboratory tent and semi-intensive care of Ebola patients on-site in a remote part of Guinea: a paradigm shift based on a bleach-sensitive point-of-care device. Clinical Chemistry and Laboratory Medicine. 2017;55(12):1881–1890.
   PubMed Web of Science ®Google Scholar
• Jansen Van Vuren P, Grobbelaar A, Storm N, et al. Comparative evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola assay. J Clin Microbiol. 2016;54(2):359–367.
   PubMed Web of Science ®Google Scholar
• Jelden KC, Iwen PC, Herstein JJ, et al. U.S. Ebola Treatment Center Clinical Laboratory Support. J Clin Microbiol. 2016;54(4):1031–1035.
   PubMed Web of Science ®Google Scholar
• Kost GJ. Point-of-care testing for Ebola and other highly infectious threats: principles, practice, and strategies for stopping outbreaks. In: Shephard M, editor. A Practical Guide to Global Point-of-care Testing. Australia: CSIRO (Commonwealth Scientific and Industrial Research Organization); 2016. p. 291–305.
   Google Scholar
• Kost GJ, Ferguson W, Truong A-T, et al. Molecular detection and point-of-care testing in Ebola virus disease and other threats: a new global public health framework to stop outbreaks. Expert Rev Mol Diagn. 2015;15(10):1245–1259.
   PubMed Web of Science ®Google Scholar
• Kost GJ, Ferguson WJ, Hoe J, et al. The Ebola Spatial Care Path: accelerating point-of-care diagnosis, decision making, and community resilience in outbreaks. Am J Disaster Med. 2015;10(2):121–143.
   PubMedGoogle Scholar
• Krahling V, Becker D, Rohde C, et al. Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med Microbiol Immunol. 2016;205(2):173–183.
   PubMed Web of Science ®Google Scholar
• Kurosaki Y, Grolla A, Fukuma A, et al. Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method. J Clin Microbiol. 2010;48(7):2330–2336.
   PubMed Web of Science ®Google Scholar
• LeBlanc JJ, Heinstein C, MacDonald J, et al. Pushing the limits of chemistry point-of-care testing for the management of patients under investigation for Ebola virus disease. Ann Clin Biochem. 2016;53(Pt 2):288–291.
   PubMed Web of Science ®Google Scholar
• Levine AC, Shetty PP, Burbach R, et al. Derivation and Internal Validation of the Ebola Prediction Score for Risk Stratification of Patients With Suspected Ebola Virus Disease. Ann Emerg Med. 2015;66(3):285–93.e1.
   PubMed Web of Science ®Google Scholar
• Liu J, Ochieng C, Wiersma S, et al. Development of a taqman array card for acute-febrile-illness outbreak investigation and surveillance of emerging pathogens, including Ebola Virus. J Clin Microbiol. 2016;54(1):49–58.
   PubMed Web of Science ®Google Scholar
• Magro L, Jacquelin B, Escadafal C, et al. Paper-based RNA detection and multiplexed analysis for Ebola virus diagnostics. Sci Rep. 2017;7(1):1347.
   PubMedGoogle Scholar
• Moschos SA. Ebola check: delivering molecular diagnostics at the point of need. Hell J Nucl Med. 2015;18(Suppl 1):144.
   PubMedGoogle Scholar
• Moschos SA. Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis. Expert Rev Mol Diagn. 2015;15(10):1237–1240.
   PubMed Web of Science ®Google Scholar
• Nicholson-Roberts T, Fletcher T, Rees P, et al. Ebola virus disease managed with blood product replacement and point of care tests in Sierra Leone. QJM: Monthly Journal of the Association of Physicians. 2015;108(7):571–572.
   PubMed Web of Science ®Google Scholar
• O’Shea MK, Clay KA, Craig DG, et al. Diagnosis of febrile illnesses other than Ebola Virus Disease at an Ebola treatment unit in Sierra Leone. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2015;61(5):795–798.
   PubMed Web of Science ®Google Scholar
• Owen WE, Caron JE, Genzen JR. Liver function testing on the Abaxis Piccolo Xpress: use in Ebola virus disease protocols. Clin Chim Acta. 2015;446:119–127.
   PubMed Web of Science ®Google Scholar
• Phan JC, Pettitt J, George JS, et al. Lateral flow immunoassays for Ebola Virus disease detection in Liberia. J Infect Dis. 2016;214(suppl 3):S222–s8.
   PubMedGoogle Scholar
• Pollock NR, Wonderly B. Evaluating novel diagnostics in an outbreak setting: lessons learned from Ebola. J Clin Microbiol. 2017;55(5):1255–1261.
   PubMed Web of Science ®Google Scholar
• Raftery P, Condell O, Wasunna C, et al. Establishing Ebola Virus Disease (EVD) diagnostics using GeneXpert technology at a mobile laboratory in Liberia: impact on outbreak response, case management and laboratory systems strengthening. PLoS Negl Trop Dis. 2018;12(1):e0006135.
   PubMed Web of Science ®Google Scholar
• Rieger T, Kerber R, El Halas H, et al. Evaluation of realstar reverse transcription-polymerase chain reaction kits for Filovirus detection in the laboratory and field. J Infect Dis. 2016;214(suppl 3):S243–s9.
   PubMedGoogle Scholar
• Rosenstierne MW, Karlberg H, Bragstad K, et al. Rapid bedside inactivation of Ebola Virus for safe nucleic acid tests. J Clin Microbiol. 2016;54(10):2521–2529.
   PubMed Web of Science ®Google Scholar
• Schieffelin J, Moses LM, Shaffer J, et al. Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: design rationale and challenges to implementation. Clin Trials. 2016;13(1):66–72.
   PubMed Web of Science ®Google Scholar
• Semper AE, Broadhurst MJ, Richards J, et al. Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: a field evaluation study. PLoS Med. 2016;13(3):e1001980.
   PubMed Web of Science ®Google Scholar
• Southern TR, Racsa LD, Albarino CG, et al. Comparison of filmarray and quantitative real-time reverse transcriptase pcr for detection of Zaire Ebolavirus from contrived and clinical specimens. J Clin Microbiol. 2015;53(9):2956–2960.
   PubMed Web of Science ®Google Scholar
• Storry JR, Persson KE. Säkerhetslaboratorium underlättar hantering av smittor som ebola. Lakartidningen. 2016;113.
   Google Scholar
• Strecker T, Palyi B, Ellerbrok H, et al. Field evaluation of capillary blood samples as a collection specimen for the rapid diagnosis of Ebola Virus Infection during an outbreak emergency. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2015;61(5):669–675.
   PubMed Web of Science ®Google Scholar
• Van Griensven J, Bah EI, Haba N, et al. Electrolyte and metabolic disturbances in Ebola Patients during a clinical trial, Guinea, 2015. Emerg Infect Dis. 2016;22:12.
   Web of Science ®Google Scholar
• VanSteelandt A, Aho J, Franklin K, et al. Operational evaluation of rapid diagnostic testing for Ebola Virus Disease in Guinean laboratories. PloS One. 2017;12(11):e0188047.
   PubMed Web of Science ®Google Scholar
• Weller SA, Bailey D, Matthews S, et al. Evaluation of the Biofire FilmArray BioThreat-E Test (v2.5) for Rapid Identification of Ebola Virus Disease in Heat-Treated Blood Samples Obtained in Sierra Leone and the United Kingdom. J Clin Microbiol. 2016;54(1):114–119.
   PubMed Web of Science ®Google Scholar
• Wolfel R, Stoecker K, Fleischmann E, et al. Mobile diagnostics in outbreak response, not only for Ebola: a blueprint for a modular and robust field laboratory. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 2015;20:44.
   Google Scholar
• Zantek ND, Hayward CP, Simcox TG, et al. An assessment of the state of current practice in coagulation laboratories. Am J Clin Pathol. 2016;146(3):378–383.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gong Y, Wang C, et al. Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic. PLoS Negl Trop Dis. 2017;11(5):e0005622.
   PubMed Web of Science ®Google Scholar
• GAO. Rapid simultaneous diagnosis of multiple human infectious diseases. Washington, DC;General Accountability Office of the US government. September 2017.
   Google Scholar
• GAO. Medical devices: capabilities and challenges of technologies to enable rapid diagnoses of infectious diseases. Washington DC;General Accountability Office of the US government. August 2017.
   Google Scholar
• GAO. Emerging infectious diseases: actions needed to address the challenges of responding to Zika Virus Disease Outbreaks. Washington, DC;General Accountability Office of the US government. May 2017.
   Google Scholar
• GAO. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance. Washington, DC;General Accountability Office of the US government. January 2017.
   Google Scholar
• GAO. Emergency funding for Ebola response—some usaid reimbursements did not comply with legislative requirements and need to be reversed. Washington, DC;General Accountability Office of the US government. November 2016.
   Google Scholar
• GAO. Infectious disease preparedness: federal challenges in responding to Influenza Outbreaks. Washington, DC;General Accountability Office of the US government. September 2004.
   Google Scholar
• GAO. Global health: framework for infectious disease surveillance. Washington, DC;General Accountability Office of the US government. 2000.
   Google Scholar
• Dubov A, Appleton JH, Campbell S. Ebola virus preparedness: emerging viruses and ethics in laboratory medicine. Arch Pathol Lab Med. 2016;140(2):171–180.
   PubMed Web of Science ®Google Scholar
• FDA. Emergency use authorization of medical products and related authorities: guidance for industry and other stakeholders. Silver Springs, MD: Scientist OotC; 2017. Contract No.: OMB Control No. 0910-0595. 2017 Jan 1.
   Google Scholar
• Kost GJ. Preventing medical errors in point-of-care testing: security, validation, performance, safeguards, and connectivity. Arch Pathol Lab Med. 2001;125:1307–1315.
   PubMed Web of Science ®Google Scholar
• Balajee SA, Arthur R, Mounts AW. Global health security: building capacities for early event detection, epidemiologic workforce, and laboratory response. Health Security. 2016;14(6):424–432.
   PubMed Web of Science ®Google Scholar
• Kost GJ. National Point-of-Care (POC) Testing Policy and Guidelines: A roadmap for African Nations. WorldLab2017—International Congress of Clinical Chemistry and Laboratory Medicine, Meeting of the South African Association for Clinical Biochemistry, and Congress of the African Federation of Clinical Chemistry; Durban, South Africa, 2017 Oct 22-25.
   Google Scholar
• Herstein JJ, Biddinger PD, Gibbs SG, et al. US State Public Health Departments Special Pathogen Planning. Journal of Public Health Management and Practice. JPHMP. 2017.
   PubMedGoogle Scholar
• Kennedy SB, Dogba JB, Wasunna CL, et al. Pre-Ebola virus disease laboratory system and related challenges in Liberia. African Journal of Laboratory Medicine. 2016;5(3):508.
   PubMed Web of Science ®Google Scholar
• Kost GJ, Husain MB. National point of care testing policy and guidelines in Malaysia, standards of care, and impact worldwide. In: Kost GJE, Curtis C Assoc., Ed. Global Point of Care: strategies for Disasters, Emergencies, and Public Health Resilience. Washington, DC: AACC Press-Elsevier; 2015. p. 595–610.
   Google Scholar
• Lamontagne F, Fowler RA, Adhikari NK, et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet (London, England). 2018 Feb 17;391(10121):700-708.
   Google Scholar
• Le AB, Buehler SA, Maniscalco PM, et al. Determining training and education needs pertaining to highly infectious disease preparedness and response: A gap analysis survey of US emergency medical services practitioners. Am J Infect Control. 2018;46(3):246–252.
   PubMed Web of Science ®Google Scholar
• Louie RFFW, Curtis CM, Kost GJ. The impact of environmental stress on diagnostic testing and implications for patient care during crisis response. In: Kost GJE, Curtis C Assoc., Ed. Global point of care: strategies for disasters, emergencies, and public health resilience. Washington, DC: AACC Press-Elsevier; 2015. p. 293–306.
   Google Scholar
• Pincha Baduge MS, Morphet J, Moss C. Emergency nurses’ and department preparedness for an ebola outbreak: A (narrative) literature review. In: International emergency nursing. 2018 May;38:41-49.
   Google Scholar
• Swaan CM, Ory AV, Schol LGC, et al. Ebola preparedness in the Netherlands: the need for coordination between the public health and the curative sector. Journal of Public Health Management and Practice: JPHMP. 2018;24(1):18–25.
   PubMed Web of Science ®Google Scholar
• Umubyeyi AN, Bonsu F, Chimzizi R, et al. The role of technical assistance in expanding access to Xpert(I) MTB/RIF: experience in sub-Saharan Africa. Public Health Action. 2016;6(1):32–34.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva, Switzerland: World Health Organization; 2016.
   Google Scholar
• Logue J, Tuznik K, Follmann D, et al. Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the alpha diagnostic international assay. Virol Methods. 2018;255:84–90.
   PubMed Web of Science ®Google Scholar
• Harmon JR, Nichol ST, Spiropoulou CF, et al. Whole blood-based multiplex immunoassays for the evaluation of human biomarker responses to emerging viruses in resource-limited regions. Viral Immunol. 2017;30(9):671–674.
   PubMed Web of Science ®Google Scholar
• Clark DJ, Tyson J, Sails AD, et al. The current landscape of nucleic acid tests for filovirus detection. J Clin Virol. 2018 Jun;103:27–36. Epub 2018 Mar 22.
   PubMed Web of Science ®Google Scholar
• McDowell A, Raizada N, Khaparde SD, et al. Before Xpert I only had my expertise”: A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities. PLoS ONE. 2018;13(3):e0193656.
   PubMed Web of Science ®Google Scholar
• Mashamba-Thompson TP, Sartorius B, Drain PK. Operational assessment of point-of-care diagnostics in rural primary healthcare clinics of KwaZulu-Natal, South Africa: a cross-sectional survey. BMC Health Serv Res. 2018;18(380):1–8.
   PubMedGoogle Scholar
• Gonzalez JP, Wauquier N, Vincent T. Revisiting Ebola, a quiet river in the heart of Africa. Med Sante Trop. 2018;281:12–17.
   Google Scholar
• Donaldson H, Lucey D. Enhancing preparation for large Nipah outbreaks beyond Bangladesh: preventing a tragedy like Ebola in West Africa. Int J Infect Dis. 2018 Jun 4;pii: S1201-9712(18):4–34425. Epub ahead of print.
   Google Scholar